Endoscopic therapies proves effective for Barrett’s esophagus
Patients with Barrett’s esophagus and early or precancerous cells significantly benefit from minimally invasive therapy delivered through an endoscope, according to a new study by
Patients with Barrett’s esophagus and early or precancerous cells significantly benefit from minimally invasive therapy delivered through an endoscope, according to a new study by
Smokeless tobacco users who said they didn’t want to quit changed their minds or significantly cut back their use when given nicotine lozenges or tobacco-free
The James Graham Brown Cancer Center at the University of Louisville is among a growing number of facilities working to improve care for head and
DentalEZ Group is teaming up with Henry Schein and the Oral Cancer Foundation to provide free oral cancer screenings at this year’s Chicago Midwinter Dental
While cancer survival rates are improving, common cancer therapies such as chemoradiation often cause acute oral complications and toxicities that are largely unavoidable, according to
The February Journal of the California Dental Association explores salivary diagnostics, taking a significant posture in dentistry based on its recent advancements in the basic,
Computed tomography (CT) texture analysis of primary tumors may be a potential imaging biomarker in localized esophageal cancer following neoadjuvant chemotherapy, according to research presented
Soligenix, a development-stage biopharmaceutical company, has formed a medical advisory board to provide medical/clinical strategic guidance to the company as it advances the development of
DentalEZ Group has unveiled the next-generation version of the Identafi oral cancer screening device from its StarDental division. Now available, the new version features a
Researchers at the Wellman Center for Photomedicine at Massachusetts General Hospital (MGH) have developed an imaging system enclosed in a capsule about the size of
Marijuana has long been used to help cancer patients better tolerate the side effects of chemotherapy. Now new research at the New York University College
Although a large majority of head and neck cancers (HNC) have a deregulation of the PI3K/AKT/mTOR pathway, deregulation of this pathway does not necessarily signify